These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 11128567

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Efficacy of combination of ondansetron injection and tablet in CAF-induced emesis in breast cancer patients].
    Shinohara H, Yonekawa H, Machimura T, Furukawa T, Nishihori H, Kurihara N, Urakami H, Nemoto Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):397-402. PubMed ID: 9492834
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review.
    Marschner N.
    Eur J Cancer; 1991 Feb; 27 Suppl 1():S15-7; discussion S22. PubMed ID: 1831629
    [Abstract] [Full Text] [Related]

  • 33. Acute and anticipatory emesis in breast cancer patients.
    Fernández-Marcos A, Martín M, Sanchez JJ, Rodriguez-Lescure A, Casado A, López Martin JA, Diaz-Rubio E.
    Support Care Cancer; 1996 Sep; 4(5):370-7. PubMed ID: 8883231
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
    Mantovani G, Macciò A, Curreli L, Lampis B, Ghiani M, Bianchi A, Contu P.
    Oncol Rep; 1998 Sep; 5(1):273-80. PubMed ID: 9458381
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Improved control of emesis and quality of life with ondansetron in breast cancer.
    Clavel M, Soukop M, Greenstreet YL.
    Oncology; 1993 Sep; 50(3):180-5. PubMed ID: 8459989
    [Abstract] [Full Text] [Related]

  • 40. Antiemetic efficacy of ondansetron and metoclopramide, both combined with corticosteroid, in malignant lymphoma patients receiving non-cisplatin chemotherapy.
    Jørgensen M, Victor MA.
    Acta Oncol; 1996 Sep; 35(2):159-63. PubMed ID: 8639310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.